Efthymios Manolis
Impact in
- Statistics and Probability top 5%
- Statistical Methods in Clinical Trials
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Statistical Methods in Clinical Trials 10
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 2
- Co-authors
- Gérard Pons (2 shared papers)Spiros Vamvakas (3 shared papers)Marco Cavaleri (1 shared paper)Kristin Karlsson (5 shared papers)Flora T. Musuamba (6 shared papers)Rajanikanth Madabushi (1 shared paper)Alexander Staab (1 shared paper)Robert Hemmings (2 shared papers)
- Journals
- CPT Pharmacometrics & Systems Pharmacology (7 papers)British Journal of Clinical Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)PROTEOMICS - CLINICAL APPLICATIONS (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- NetherlandsSwedenBelgium
In The Last Decade
Efthymios Manolis
18 papers receiving 591 citations
Peers
Comparison fields: 5 of 95
- Statistics and Probability 104
- Pharmacology 85
- Hepatology 63
- Pediatrics, Perinatology and Child Health 139
- Pharmacology 73
Countries citing papers authored by Efthymios Manolis
This map shows the geographic impact of Efthymios Manolis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efthymios Manolis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efthymios Manolis more than expected).
Fields of papers citing papers by Efthymios Manolis
This network shows the impact of papers produced by Efthymios Manolis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efthymios Manolis. The network helps show where Efthymios Manolis may publish in the future.
Co-authors
The 25 scholars most cited alongside Efthymios Manolis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 89 | |
| 2 | 2009 | 85 | |
| 3 | 2018 | 85 | |
| 4 | 2004 | 65 | |
| 5 | 2011 | 62 | |
| 6 | 2013 | 44 | |
| 7 | 2019 | 34 | |
| 8 | 2015 | 33 | |
| 9 | 2011 | 30 | |
| 10 | 2020 | 19 | |
| 11 | 2013 | 12 | |
| 12 | 2023 | 12 | |
| 13 | 2014 | 10 | |
| 14 | 2021 | 9 | |
| 15 | 2025 | 8 | |
| 16 | 2015 | 6 | |
| 17 | 2024 | 5 | |
| 18 | 2020 | 2 |
About Efthymios Manolis
Efthymios Manolis is a scholar working on Statistics and Probability, Economics and Econometrics, Pediatrics, Perinatology and Child Health, Computational Theory and Mathematics and Pharmacology, having authored 18 papers that have together received 610 indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (10 papers), Pharmaceutical studies and practices (7 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmacogenetics and Drug Metabolism (4 papers), Computational Drug Discovery Methods (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Pharmaceutical Economics and Policy (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (1 paper). The work is most often cited by research in Statistics and Probability (104 citations), Pharmacology (85 citations), Hepatology (63 citations), Pediatrics, Perinatology and Child Health (139 citations) and Pharmacology (73 citations). Efthymios Manolis has collaborated with scholars based in Netherlands, Sweden and Belgium. Frequent co-authors include Gérard Pons, Spiros Vamvakas, Marco Cavaleri, Kristin Karlsson, Flora T. Musuamba, Rajanikanth Madabushi, Alexander Staab, Robert Hemmings, Sandra A. G. Visser and Scott Marshall. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, PROTEOMICS - CLINICAL APPLICATIONS and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.